Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.790
+0.050 (2.87%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $50.02 million as of April 17, 2025. Its market cap has decreased by -22.71% in one year.
Market Cap
50.02M
Enterprise Value
40.28M
1-Year Change
-22.71%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $50.02M, a decrease of -59.87%. That is a compound annual growth rate of -20.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 50.02M | -12.70% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| UnitedHealth Group | 533.82B |
| Johnson & Johnson | 370.25B |
| AbbVie | 312.76B |
| Novo Nordisk | 286.28B |
| Abbott Laboratories | 218.91B |
| AstraZeneca | 210.97B |
| Novartis AG | 209.02B |